Physician profile
Richard Tipperman
NPI 1730153024
$111,039.26
in general payments reported to CMS, 2019-2025
10 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $14K · 2021: $7,939 · 2022: $10K · 2023: $5,586 · 2024: $16K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Food and Beverage: $2,356 · Travel and Lodging: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,172.38 |
| Food and Beverage | $2,356.07 |
| Travel and Lodging | $1,254.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $53,786.63 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Clareon, Acrysof Iq Vivity |
| Alcon Research LLC | $46,137.00 | 2019-2025 | Unity |
| Beaver-Visitec International, INC. | $9,317.88 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $1,500.00 | 2019 | |
| Allergan, INC. | $124.99 | 2019 | |
| New World Medical,INC. | $69.18 | 2024-2025 | Streamline, Clearpath, Ahmed Glaucoma Valve |
| Abbvie INC. | $52.17 | 2024-2025 | |
| Rayner Intraocular Lenses Limited | $20.51 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Tipperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.